Literature DB >> 35997932

Response to " Comment on: Alarmists at the Gates: Esophageal Adenocarcinoma After Sleeve Gastrectomy Is Not Different than with Other Bariatric/Metabolic Surgery".

Michel Gagner1,2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35997932     DOI: 10.1007/s11695-022-06242-2

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   3.479


× No keyword cloud information.
  4 in total

1.  Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial.

Authors:  Paulina Salminen; Sofia Grönroos; Mika Helmiö; Saija Hurme; Anne Juuti; Risto Juusela; Pipsa Peromaa-Haavisto; Marja Leivonen; Pirjo Nuutila; Jari Ovaska
Journal:  JAMA Surg       Date:  2022-08-01       Impact factor: 16.681

2.  Response to " Comment on: Alarmists at the Gates: Esophageal Adenocarcinoma After Sleeve Gastrectomy Is Not Different than with Other Bariatric/Metabolic Surgery".

Authors:  Michel Gagner
Journal:  Obes Surg       Date:  2022-08-23       Impact factor: 3.479

3.  Staple Line Intrathoracic Migration After Sleeve Gastrectomy: Correlation between Symptoms, CT Three-Dimensional Stomach Analysis, and 24-h pH Monitoring.

Authors:  Pascale Karila-Cohen; Anne-Laure Pelletier; Loukbi Saker; Cédric Laouénan; Delphine Bachelet; Antoine Khalil; Konstantinos Arapis
Journal:  Obes Surg       Date:  2022-05-02       Impact factor: 3.479

  4 in total
  2 in total

1.  Comment on: Alarmists at the Gates: Esophageal Adenocarcinoma After Sleeve Gastrectomy Is Not Different than with Other Bariatric/Metabolic Surgeries.

Authors:  Alfredo Genco; Lidia Castagneto-Gissey; Giovanni Casella
Journal:  Obes Surg       Date:  2022-08-13       Impact factor: 3.479

2.  Response to " Comment on: Alarmists at the Gates: Esophageal Adenocarcinoma After Sleeve Gastrectomy Is Not Different than with Other Bariatric/Metabolic Surgery".

Authors:  Michel Gagner
Journal:  Obes Surg       Date:  2022-08-23       Impact factor: 3.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.